UGT1A1*6 AND UGT1A1*27 ARE ASSOCIATED WITH IRINOTECAN-INDUCED SEVERE NEUTROPENIA IN JAPANESE PATIENTS WITH NSCLC

被引:0
|
作者
Doi, S. [1 ]
Nakamura, Y. [1 ]
Fukuda, M. [2 ,3 ]
Takatani, H. [2 ]
Fukuda, M. [2 ,3 ]
Kinoshita, A. [4 ]
Soda, H. [5 ]
Oka, M. [6 ]
Tsukamoto, K. [7 ]
Kohno, S. [1 ]
机构
[1] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan
[2] Japanese Red Cross Nagasaki Atom Bomb Hosp, Nagasaki, Japan
[3] Nagasaki Municipal Hosp, Nagasaki, Japan
[4] NHO Nagasaki Med Ctr, Ohmura, Japan
[5] Sasebo Gen Hosp, Sasebo, Japan
[6] Kawasaki Med Sch, Div Resp Dis, Kurashiki, Okayama 70101, Japan
[7] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmacotherapeut, Nagasaki 852, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:165 / 165
页数:1
相关论文
共 50 条
  • [41] Meta-analysis revisiting the influence of UGT1A1*28 and UGT1A1*6 on irinotecan safety in colorectal cancer patients
    Thu Nguyen, Cuc Thi
    Minh Thuy, Nguyen Thi
    Huong, Phung Thanh
    PHARMACOGENOMICS, 2024, 25 (10-11) : 469 - 477
  • [42] The relationship between the UGT1A1*27 and UGT1A1*7 genetic polymorphisms and irinotecan-related toxicities in patients with lung cancer
    Fukuda, Minoru
    Okumura, Manabu
    Iwakiri, Tomomi
    Kazuhiko, Arimori
    Takemoto, Shinnosuke
    Ikeda, Takaya
    Honda, Takuya
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Kobayashi, Kazuma
    Masutani, Mitsuko
    Oka, Mikio
    Ashizawa, Kazuto
    Mukae, Hiroshi
    CANCER RESEARCH, 2017, 77
  • [43] Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
    Amandito, Radhian
    Rohsiswatmo, Rinawati
    Carolina, Erica
    Maulida, Rizka
    Kresnawati, Windhi
    Malik, Amarila
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [44] Fluoropyrimidine- and irinotecan-induced toxicity profile associated with mutations in DPYD and UGT1A1 genes
    Teran Brage, E.
    Cigarral Garcia, B.
    Heredero Jung, D.
    Garcia Berrocal, B.
    Navarro Martin, M.
    Navalon Jimenez, M.
    Fonseca Sanchez, E.
    Vidal Tocino, R.
    ANNALS OF ONCOLOGY, 2022, 33 : S323 - S323
  • [45] Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese:: roles of UGT1A1*6 and*28
    Minami, Hironobu
    Sai, Kimie
    Saeki, Mayumi
    Saito, Yoshiro
    Ozawa, Shogo
    Suzuki, Kazuhiro
    Kaniwa, Nahoko
    Sawada, Jun-ichi
    Hamaguchi, Tetsuya
    Yamamoto, Noboru
    Shirao, Kuniaki
    Yamada, Yasuhide
    Ohmatsu, Hironobu
    Kubota, Kaoru
    Yoshida, Teruhiko
    Ohtsu, Atsushi
    Saijo, Nagahiro
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (07): : 497 - 504
  • [46] Linkage disequilibrium of UGT1A1*6 and UGT1A1*28 in relation to UGT1A6 and UGT1A7 polymorphisms
    Urawa, Naohito
    Kobayashi, Yoshinao
    Araki, Jun
    Sugimoto, Ryosuke
    Iwasa, Motoh
    Kaito, Masahiko
    Adachi, Yukihko
    ONCOLOGY REPORTS, 2006, 16 (04) : 801 - 806
  • [47] Commentary: Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
    Heydari, Mohammad Reza
    Fardaei, Majid
    FRONTIERS IN PEDIATRICS, 2020, 7
  • [48] Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1☆28 and/or UGT1A1☆6 polymorphisms
    Satoh, Taroh
    Ura, Takashi
    Yamada, Yasuhide
    Yamazaki, Kentaro
    Tsujinaka, Toshimasa
    Munakata, Masaki
    Nishina, Tomohiro
    Okamura, Shu
    Esaki, Taito
    Sasaki, Yasutsuna
    Koizumi, Wasaburo
    Kakeji, Yoshihiro
    Ishizuka, Naoki
    Hyodo, Ichinosuke
    Sakata, Yuh
    CANCER SCIENCE, 2011, 102 (10) : 1868 - 1873
  • [49] Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients
    Jing Gao
    Jun Zhou
    Yanyan Li
    Zhi Peng
    Yilin Li
    Xicheng Wang
    Lin Shen
    Medical Oncology, 2013, 30
  • [50] Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients
    Gao, Jing
    Zhou, Jun
    Li, Yanyan
    Peng, Zhi
    Li, Yilin
    Wang, Xicheng
    Shen, Lin
    MEDICAL ONCOLOGY, 2013, 30 (03)